Status:
COMPLETED
National Survey on GERD Patients (Adults and Children)
Lead Sponsor:
AstraZeneca
Conditions:
GERD (Gastroesophageal Reflux Disease)
Eligibility:
All Genders
Brief Summary
To describe GERD digestive expression according to ages: - children (from 0 to 23 months) and (24 months and more)- adults (from 18 to 29 years old), (from 30 to 39 years old), (from 40 to 49 years ol...
Eligibility Criteria
Inclusion
- Adults : - Male or female \> or = 18 years old - With at least one GERD typical clinical sign (pyrosis and / or acid regurgitations).- Not receiving any GERD treatment within the 3 previous months.
- Children :- Male or female \< 18 years old - With GERD digestive clinical signs during the consultation (receiving treatment or not)- Whose parents or legal guardian gave oral approval to the child participation in the survey.
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2009
Estimated Enrollment :
4400 Patients enrolled
Trial Details
Trial ID
NCT00833573
Start Date
January 1 2009
End Date
October 1 2009
Last Update
November 17 2009
Active Locations (1053)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Abbaretz, France
2
Research Site
Abbeville, France
3
Research Site
Acheux-en-Amiénois, France
4
Research Site
Achicourt, France